Edina Silajdzic

Summary

Affiliation: Lund University
Country: Sweden

Publications

  1. doi request reprint Antibodies against phosphorylcholine are not altered in plasma of patients with Alzheimer's disease
    Edina Silajdzic
    Brain Disease Biomarker Unit, Department of Experimental Medical Science, Wallenberg Neuroscience Center, Lund University, Lund, Sweden
    BMC Neurol 15:8. 2015
  2. pmc No diagnostic value of plasma clusterin in Alzheimer's disease
    Edina Silajdzic
    Brain Disease Biomarker Unit, Department of Experimental Medical Science, Wallenberg Neuroscience Center, Lund University, Lund, Sweden
    PLoS ONE 7:e50237. 2012
  3. doi request reprint Flt3 ligand does not differentiate between Parkinsonian disorders
    Edina Silajdzic
    Brain Disease Biomarker Unit, Department of Experimental Medical Science, Wallenberg Neuroscience Center, Lund University, Lund, Sweden
    Mov Disord 29:1319-22. 2014

Detail Information

Publications3

  1. doi request reprint Antibodies against phosphorylcholine are not altered in plasma of patients with Alzheimer's disease
    Edina Silajdzic
    Brain Disease Biomarker Unit, Department of Experimental Medical Science, Wallenberg Neuroscience Center, Lund University, Lund, Sweden
    BMC Neurol 15:8. 2015
    ..It has been shown that patients with Alzheimer's disease and other dementias have significantly lower serum anti-PC levels compared to controls, suggesting that low levels of atheroprotective anti-PC may play a role in AD and dementia...
  2. pmc No diagnostic value of plasma clusterin in Alzheimer's disease
    Edina Silajdzic
    Brain Disease Biomarker Unit, Department of Experimental Medical Science, Wallenberg Neuroscience Center, Lund University, Lund, Sweden
    PLoS ONE 7:e50237. 2012
    ..There was a slight, but significant, increase in plasma clusterin in patients with depression compared to all other groups tested, which may warrant further investigation...
  3. doi request reprint Flt3 ligand does not differentiate between Parkinsonian disorders
    Edina Silajdzic
    Brain Disease Biomarker Unit, Department of Experimental Medical Science, Wallenberg Neuroscience Center, Lund University, Lund, Sweden
    Mov Disord 29:1319-22. 2014
    ..It has been reported that flt3 ligand levels in cerebrospinal fluid could clearly differentiate patients with Parkinson's disease from patients with multiple system atrophy, with 99% sensitivity and 95% specificity...